NCT07088406 A Multi-level Mother-daughter Physical Activity Intervention for Pre- Adolescent Latinas
| NCT ID | NCT07088406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Physical Activity |
| Study Type | INTERVENTIONAL |
| Enrollment | 432 participants |
| Start Date | 2025-08-21 |
| Primary Completion | 2029-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 432 participants in total. It began in 2025-08-21 with a primary completion date of 2029-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this Cluster Randomized Control Trial (RCT) is to learn if the mother-daughter intervention titled "Conmigo" can increase Latina preadolescents' physical activity (PA). The main objectives of the study are: * To test the effectiveness of Conmigo on daughters' Moderate-to-Vigorous level PA (MVPA) over time * To evaluate individual (e.g. mothers' MVPA) and family level (e.g. mother-daughter communication) mechanisms of change and their bidirectional effects Researchers will compare the 10-week physical activity promotion intervention to a 10-week parallel intervention with emphasis on another health behavior (dietary intake) to see if there are differences in MVPA levels. We will enroll 216 Latina mother-daughter pairs at 18 elementary schools; each school will randomly receive the PA intervention or the control group program. Mothers and daughters will attend 10 weekly sessions (2 hours each) at their elementary school, led by YMCA staff. Informed by social cognitive theory and family systems theory, the PA intervention sessions target family-level correlates of physical activity such as PA promotion parenting strategies (monitoring, role-modeling, etc.) and mother-daughter communication. Participants in the intervention group engage in weekly PA during sessions, discuss different topics each week, and set goals and receive PA homework during the week. The investigators hypothesize that daughters participating in Conmigo will have higher minutes of device-assessed MVPA at M2 (post program), M3 (6 months post program), and M4 (12-months post program) compared to girls in the control condition.
Eligibility Criteria
Inclusion Criteria (DAUGHTER): * Self-identifying as Latina * aged 8-11 * not currently meeting CDC's 2018 PA guidelines (60 min MVPA/day) * attends an elementary school enrolled in the study * speaks English or Spanish Inclusion Criteria (MOTHER): * Self-identifying as Latina * primary female caregiver (living with her ≥4 days/week) of the daughter * speaks English or Spanish * both Mother \& Daughter can attend weekly program activities for 10 weeks, and intend to stay in the area for the study's duration. Exclusion criteria: * either Mother or Daughter has a health condition that precludes them from doing PA * cognitive impairment affecting participation, * inability for mother to provide informed consent or daughter to provide assent in English or Spanish
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07088406 clinical trial?
This trial is open to female participants only, aged 8 Years or older, up to 65 Years, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07088406 currently recruiting?
Yes, NCT07088406 is actively recruiting participants. Contact the research team at earredon@sdsu.edu for enrollment information.
Where is the NCT07088406 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT07088406 clinical trial?
NCT07088406 is sponsored by San Diego State University. The trial plans to enroll 432 participants.